Kleem Chaudhary Checkmate Pharmaceuticals, Inc. (CMPI) insider trading activity

CMPI Quotes by TradingView

Kleem Chaudhary is Chief Business Officer of Checkmate Pharmaceuticals, Inc.. Currently has a direct ownership of 8,000 shares of CMPI, which is worth approximately $83,920. The most recent transaction as insider was on Feb 26, 2021, when has been sold 2,000 shares (Common Stock) at a price of $2.62 per share, resulting in proceeds of $5,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8K
0% 3M change
0% 12M change
Total Value Held $83,920

Kleem Chaudhary Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2021
BUY
Exercise of conversion of derivative security
$5,240 $2.62 p/Share
2,000 Added 20.0%
8,000 Common Stock
Jan 14 2021
BUY
Exercise of conversion of derivative security
$5,240 $2.62 p/Share
2,000 Added 25.0%
6,000 Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$10,480 $2.62 p/Share
4,000 Added 50.0%
4,000 Common Stock
KC

Kleem Chaudhary

Chief Business Officer
Cambridge, MA

Track Institutional and Insider Activities on CMPI

Follow Checkmate Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMPI shares.

Notify only if

Insider Trading

Get notified when an Checkmate Pharmaceuticals, Inc. insider buys or sells CMPI shares.

Notify only if

News

Receive news related to Checkmate Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CMPI